The debut of a China-developed medical device in the world's oldest and best-known medical journal has been hailed by Chinese media as a breakthrough for Chinese medical innovation. 

For the first time in its 200-year history, The Lancet published Tuesday a report on the clinical tests of a China-made device, the Firehawk stent, a drug-eluting stent independently developed by the Shanghai-based MicroPort Scientific Corporation.

The Firehawk is a stent that contains drugs in tiny grooves engraved by lasers on the surface. The design effectively prevents the drug from leaking during the transportation of the stent, which greatly improves efficiency and avoids wasting medication.